Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab-Reference-Cited by-同舟云学术

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab

Published:2011-08 Issue:8 Volume:22 Page:1834-1838
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tebbutt N.C.,Murphy F.,Zannino D.,Wilson K.,Cummins M.M.,Abdi E.,Strickland A.H.,Lowenthal R.M.,Marx G.,Karapetis C.,Shannon J.,Goldstein D.,Nayagam S.S.,Blum R.,Chantrill L.,Simes R.J.,Price T.J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/8/1834/19482372/mdq702.pdf

Reference16 articles.

1. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

2. High dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG) study E3200;Giantonio;J Clin Oncol,2005

3. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study;Fuchs;J Clin Oncol,2007

4. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study;Hochster;J Clin Oncol,2008

5. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta‐analysis;Cancer Medicine;2023-12

2. A pharmacovigilance study of adverse event profiles and haemorrhagic safety of bevacizumab based on the FAERS database;Expert Opinion on Drug Safety;2023-08-20

3. Chemotherapy-induced cardiotoxicity;Galenika Medical Journal;2023

4. Gynecologic malignancies;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023

5. Myocardial Ischemia Related to Common Cancer Therapy—Prevention Insights;Life;2022-07-12